Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Capsule could reduce need for booster injections
The project is assessing the need for single-shot vaccine delivery in cattle.

Device may revolutionise human and medical sectors

Edinburgh researchers are developing a new device that releases medicine at specific times. It is hoped the device - a capsule that is implanted under the skin - could revolutionise both human and animal medicine.

The project is being delivered by The Roslin Institute and Heriot-Watt University who have been awarded £800k of funding from the Biotechnology and Biological Sciences Research Council (BBSRC).

It is assessing the potential for single-shot vaccine delivery in cattle, thereby reducing the need for booster vaccinations. Researchers say that if the project is successful, it could also be used for antibiotics, chemotherapeutics and other drugs.

The 3D-printed capsule contains a single-shot of vaccine as well as a sugar solution. The sugar pulls water through the wall of the capsure leading to pressure build-up. Eventually the capsule bursts and delivers the vaccine.

“By carefully tailoring the material properties and capsule design, we aim to achieve release at the desired time-point, without needing any intervention, said Dr Ferry PW Melchels, assistant professor at Heriot-Watt’s Institute of Biological Chemistry, Biophysics and Bioengineering.

“This will omit the need for a second visit to the doctor or a second visit from the vet; it will even allow to vaccinate wildlife without having to recapture the animals to give them their booster shots.”

Jayne Hope of The Roslin Institute added: "We are delighted to have been awarded funding from the BBSRC for this joint project with Heriot-Watt University.

"This project will investigate the potential for single-shot vaccine delivery in cattle, thereby reducing the requirement for booster immunisations. This could have a significant impact on the control of infectious diseases in livestock."

Become a member or log in to add this story to your CPD history

Voting opens for BEVA Council

News Story 1
 Eligible members of BEVA will be able to vote for their Council team until Monday, 17 August 2026. Members will have received an election email on 17 July.

There are five candidates standing for four available places on Council. They are:

  • Alexandre Triguino
  • Angela Jones
  • Beth Bryant
  • Holly Rees
  • Hugh Somerville
Full profiles for each candidate can be found on the BEVA website

Click here for more...
News Shorts
Government releases latest bluetongue statistics

APHA has confirmed the number of bluetongue cases that have been logged in the UK since 1 July 2026.

The total number of BTV-3 cases, as of 6 August, is 187. This includes 183 cases in England and four cases in Wales.

There have been no recorded cases in Scotland and Northern Ireland.

The location of premises in Great Britain where at least one animal has tested positive by PCR for BTV-3, BTV-8 or BTV-12 is available on the bluetongue case map. All livestock keepers in Great Britain are urged to familiarise themselves with nation-specific bluetongue control policies.

Bluetongue virus is a notifiable disease. It is a legal requirement that any suspicions, even if livestock has been vaccinated, are reported immediately.